TestNBankN-NPharmacology:N ANPatient-CenteredNNursingNProcessNApproachN(9thNEdition,N2017)
PHARMACOLOGYN9THNEDITIONNMCCUISTIONNTESTNBANK
ThisNisNaNsetNofNquestionsNtoNanswerNtheNquestionsNofNtheNtextbookN"Pharmacology:NANPatient-
CenteredNNursingNProcessNApproachN9thNEdition"NitNhelpsNyouNtoNbetterNunderstandNtheNbookNcorre
ctly.
GetNtheNrightNdosageNofNpharmacologyNcontentNtoNsucceedNonNtheNNCLEXNandNasNaNprofessionalNnurs
eNwithN"Pharmacology:NANPatient-
CenteredNNursingNProcessNApproach,N9thNEdition".NUsingNaNstreamlinedNprototypeNapproachNandNanN
emphasisNonNnursingNcare,NthisNtextNmakesNitNeasyNforNtoday’sNnursingNstudentsNtoNbetterNunderstand
NtheNcomplicatedNsubjectNofNpharmacology.NTheNbook’sNdetailedNchapterNonN dosageNcalculation,NtheNn
ursingNprocessNframeworkNforNdrugNtherapy,NstrongNQSENNfocus,NandNsummariesNofNprototypeNdrugsN
helpNdeliverNtheNperfect.
,TestNBankN-NPharmacology:NANPatient-
CenteredNNursingNProcessNApproachN(9thNEdition,N2017)
PHARMACOLOGYN9THNEDITIONNMCCUISTIONNTESTNBANK
Table of Contents
N N
TableNofNContents ChapterN28:NPeptides,NAntimalarial,Nand
ChapterN01:NDrugNDevelopmentNan Anthelmintic
dNEthicalNConsiderations ChapterN29:NHIV-NandNAIDS-
ChapterN02:NPharmacokinetics,N RelatedNDrugs
Pharmacodynamics,NandNPhar ChapterN30:NTransplantNDrug
macogenetics sNChapterN31:NVaccinesNChapt
ChapterN03:NCulturalNConsiderations erN32:NAnticancerNDrugs
ChapterN04:NComplementaryNandNAl
N ChapterN33:NTargetedNTherapiesNtoNTrea
ternativeNTherapies tNCancer
ChapterN05:NPediatricNConsideration ChapterN34:NBiologicNResponse
sNChapterN06:NGeriatricNConsideration Modifiers
N
sNChapterN07:NDrugsNinNSubstanceNU ChapterN35:NUpperNRespiratory
seNDisorder Disorders
N
ChapterN08:NTheNNursingNProcessNan ChapterN36:NLowerNRespiratory
dNPatient-CenteredNCare Disorders
N
ChapterN09:NSafetyNandNQualityN ChapterN37:NCardiacNGlycosides,NA
ChapterN10:NDrugNAdministration ntianginals,NandNAntidysrhythmicsN
ChapterN11:NDrugNCalculationsN
N ChapterN38:NDiuretics
ChapterN12:NFluidNVolumeNandNE ChapterN39:NAntihypertensive
lectrolytes ChapterN40:NAnticoagulants,NAntiplat
ChapterN13:NVitaminNandNMinera elets,NandNThrombolyticsNChapterN4
lNReplacement 1:NAntihyperlipidemicsNandNPeriphera
ChapterN14:NNutritionalNSupportNCha lNVasodilators
pterN15:NAdrenergicNAgonistsNandNAnt ChapterN42:NGastrointestinalNTract
agonists Disorders
N
ChapterN16:NCholinergicNAgonistsNan ChapterN43:NAntiulcerNDrugsNChapt
dNAntagonists erN44:NEyeNandNEarNDisordersNChap
ChapterN17:NStimulants terN45:NDermatologicNDisordersNCha
ChapterN18:NDepressantsNCha pterN46:NPituitary,NThyroid,NParathyr
pterN19:NAntiseizureNDrugs oid,NandNAdrenalNDisordersNChapter
ChapterN20:NDrugsNforNParkinsonismNan N47:NAntidiabetics
dNAlzheimer'sNDisease ChapterN48:NUrinaryNDisordersNChap
ChapterN21:NDrugsNforNNeuromuscula terN49:NPregnancyNandNPretermNLabo
rNDisordersNandNMuscleNSpasmsNChap r
terN22:NAntipsychoticsNandNAnxiolytics ChapterN50:NLabor,NDelivery,Nan
ChapterN23:NAntidepressantsNandNMoo dNPostpartum
dNStabilizers ChapterN51:NNeonatalNandNNewbor
ChapterN24:NAntiinflammatories nNChapterN52:NWomen'sNReproducti
ChapterN25:NAnalgesics veNHealth
ChapterN26:NAntibacterials ChapterN53:NMen'sNReproductiveNHealt
ChapterN27:NAntituberculars,NAntifungals, hNChapterN54:NSexuallyNTransmittedNInfe
andNAntivirals
N ctions
ChapterN55:NAdultNandNPediatric
,TestNBankN-NPharmacology:NANPatient-
CenteredNNursingNProcessNApproachN(9thNEdition,N2017)
PHARMACOLOGYN9THNEDITIONNMCCUISTIONNTESTNBANK
EmergencyNDrugs
, TestNBankN-NPharmacology:NANPatient-
CenteredNNursingNProcessNApproachN(9thNEdition,N2017)
PHARMACOLOGYN9THNEDITIONNMCCUISTIONNTESTNBANK
Chapter 01: Drug Development and Ethical Considerations
N N N N N N
MULTIPLENCHOICE
1. TheNnurseNisNpreparingNtoNadministerNaNscheduleNIINinjectableNdrugNandNisNdrawingNupNhalfN
ofNtheNcontentsNofNaNSingle-useNvial.NWhichNnursingNactionNisNcorrect?
a. AskNanotherNnurseNtoNobserveNandNcosignNwastingNtheNremainingNdrugNfromNtheNvial.
b. KeepNtheNremainingNamountNinNtheNpatient’sNdrawerNtoNgiveNatNtheNnextNdose.
c. RecordNtheNamountNunusedNinNtheNpatient’sNmedicationNrecord.
d. DisposeNofNtheNvialNwithNtheNremainingNdrugNintoNaNlockedNcollectionNbo
x.NANS:NA
ScheduleNIINdrugsNareNcontrolledNsubstances,NandNallNmustNbeNaccountedNfor.NWhenNwasting
NaNportionNofNaNdrug,NanotherNnurseNshouldNobserveNandNcosignNthatNaNdrugNwasNwasted.
DIF:NCOGNITIVENLEVEL:NApplyingN(Application)N
TOP:NNURSINGNPROCESS:NNursingNInterventio
n
MSC:NNCLEX:NPhysiologicalNIntegrity:NPharmacologicalNandNParenteralNTherapies
2. ANpatientNisNprescribedNaNmedicationNandNasksNtheNnurseNifNtheNdrugNisNavailableNinNaNgener
icNform.NTheNnurseNunderstandsNthatNaNgenericNmedicationNwillNhaveNaNnameNthat
a. isNaNregisteredNtrademark.
b. isNalwaysNcapitalized.
c. describesNtheNdrugsNchemicalNstructure.
d. isNnon-
proprietary.NANS:ND
TheNgenericNnameNisNtheNofficial,Nnon-
proprietaryNnameNforNaNdrug.NTheNbrandNnameNisNtheNtrademarkNnameNandNisNalwaysNcapitalized.
NTheNchemicalNnameNdescribesNtheNchemicalNstructureN ofNtheNdrug.
DIF:NCOGNITIVENLEVEL:NUnderstandingN(Comprehension
)NTOP:NNURSINGNPROCESS:NN/A
MSC:NNCLEX:NPhysiologicalNIntegrity:NPharmacologicalNandNParenteralNTherapies
3. ANpatientNreceivesNaNprescriptionNonNwhichNtheNproviderNhasNnotedNthatNaNgenericNmedicati
onNmayNbeNgiven.TheNpatientNasksNtheNnurseNwhatNthisNmeans.NWhatNwillNtheNnurseNtellNtheNpa
tientNaboutNgenericNdrugs?
a. TheyNcontainNtheNsameNinertNingredientsNasNbrand-nameNdrugs.
b. TheyNhaveNchemicalNstructuresNthatNareNidenticalNtoNproprietaryNdrugs.
c. TheyNtendNtoNbeNlessNexpensiveNthanNbrand-nameNdrugs.
d. TheyNundergoNextensiveNtestingNbeforeNtheyNareNmarkete
d.NANS:NC
GenericNdrugsNareNapprovedNbyNtheNFDANifNtheyNareNprovedNtoNbeNbioequivalentNtoNtheNbrand-
NnameNdrug.NTheyNtendNtoNbeNlessNexpensiveNbecauseNmanufacturersNofNtheseNdrugsNdoNnotNhav
eNtoNdoNtheNextensiveNtestingNrequiredNofNbrand-
nameNdrugsNbeforeNmarketing.NTheyNareNnotNidenticalNtoNbrand-
nameNdrugsNandNoftenNhaveNdifferentNinertNingredients.
DIF:NCOGNITIVENLEVEL:NApplyingN(Application)
TOP:NNURSINGNPROCESS:NNursingNIntervention:NPatientNTeachingN
MSC:NNCLEX:NManagementNofNClientNCare
4. TheNnurseNreviewsNinformationNaboutNaNdrugNandNnotesNtheNinitialsNUSPNafterNtheNdrugsNoffici
alNname.NTheNnurseNunderstandsNthatNthisNdesignationNindicatesNtheNdrug
a. isNaNcontrolledNsubstance.
PHARMACOLOGYN9THNEDITIONNMCCUISTIONNTESTNBANK
ThisNisNaNsetNofNquestionsNtoNanswerNtheNquestionsNofNtheNtextbookN"Pharmacology:NANPatient-
CenteredNNursingNProcessNApproachN9thNEdition"NitNhelpsNyouNtoNbetterNunderstandNtheNbookNcorre
ctly.
GetNtheNrightNdosageNofNpharmacologyNcontentNtoNsucceedNonNtheNNCLEXNandNasNaNprofessionalNnurs
eNwithN"Pharmacology:NANPatient-
CenteredNNursingNProcessNApproach,N9thNEdition".NUsingNaNstreamlinedNprototypeNapproachNandNanN
emphasisNonNnursingNcare,NthisNtextNmakesNitNeasyNforNtoday’sNnursingNstudentsNtoNbetterNunderstand
NtheNcomplicatedNsubjectNofNpharmacology.NTheNbook’sNdetailedNchapterNonN dosageNcalculation,NtheNn
ursingNprocessNframeworkNforNdrugNtherapy,NstrongNQSENNfocus,NandNsummariesNofNprototypeNdrugsN
helpNdeliverNtheNperfect.
,TestNBankN-NPharmacology:NANPatient-
CenteredNNursingNProcessNApproachN(9thNEdition,N2017)
PHARMACOLOGYN9THNEDITIONNMCCUISTIONNTESTNBANK
Table of Contents
N N
TableNofNContents ChapterN28:NPeptides,NAntimalarial,Nand
ChapterN01:NDrugNDevelopmentNan Anthelmintic
dNEthicalNConsiderations ChapterN29:NHIV-NandNAIDS-
ChapterN02:NPharmacokinetics,N RelatedNDrugs
Pharmacodynamics,NandNPhar ChapterN30:NTransplantNDrug
macogenetics sNChapterN31:NVaccinesNChapt
ChapterN03:NCulturalNConsiderations erN32:NAnticancerNDrugs
ChapterN04:NComplementaryNandNAl
N ChapterN33:NTargetedNTherapiesNtoNTrea
ternativeNTherapies tNCancer
ChapterN05:NPediatricNConsideration ChapterN34:NBiologicNResponse
sNChapterN06:NGeriatricNConsideration Modifiers
N
sNChapterN07:NDrugsNinNSubstanceNU ChapterN35:NUpperNRespiratory
seNDisorder Disorders
N
ChapterN08:NTheNNursingNProcessNan ChapterN36:NLowerNRespiratory
dNPatient-CenteredNCare Disorders
N
ChapterN09:NSafetyNandNQualityN ChapterN37:NCardiacNGlycosides,NA
ChapterN10:NDrugNAdministration ntianginals,NandNAntidysrhythmicsN
ChapterN11:NDrugNCalculationsN
N ChapterN38:NDiuretics
ChapterN12:NFluidNVolumeNandNE ChapterN39:NAntihypertensive
lectrolytes ChapterN40:NAnticoagulants,NAntiplat
ChapterN13:NVitaminNandNMinera elets,NandNThrombolyticsNChapterN4
lNReplacement 1:NAntihyperlipidemicsNandNPeriphera
ChapterN14:NNutritionalNSupportNCha lNVasodilators
pterN15:NAdrenergicNAgonistsNandNAnt ChapterN42:NGastrointestinalNTract
agonists Disorders
N
ChapterN16:NCholinergicNAgonistsNan ChapterN43:NAntiulcerNDrugsNChapt
dNAntagonists erN44:NEyeNandNEarNDisordersNChap
ChapterN17:NStimulants terN45:NDermatologicNDisordersNCha
ChapterN18:NDepressantsNCha pterN46:NPituitary,NThyroid,NParathyr
pterN19:NAntiseizureNDrugs oid,NandNAdrenalNDisordersNChapter
ChapterN20:NDrugsNforNParkinsonismNan N47:NAntidiabetics
dNAlzheimer'sNDisease ChapterN48:NUrinaryNDisordersNChap
ChapterN21:NDrugsNforNNeuromuscula terN49:NPregnancyNandNPretermNLabo
rNDisordersNandNMuscleNSpasmsNChap r
terN22:NAntipsychoticsNandNAnxiolytics ChapterN50:NLabor,NDelivery,Nan
ChapterN23:NAntidepressantsNandNMoo dNPostpartum
dNStabilizers ChapterN51:NNeonatalNandNNewbor
ChapterN24:NAntiinflammatories nNChapterN52:NWomen'sNReproducti
ChapterN25:NAnalgesics veNHealth
ChapterN26:NAntibacterials ChapterN53:NMen'sNReproductiveNHealt
ChapterN27:NAntituberculars,NAntifungals, hNChapterN54:NSexuallyNTransmittedNInfe
andNAntivirals
N ctions
ChapterN55:NAdultNandNPediatric
,TestNBankN-NPharmacology:NANPatient-
CenteredNNursingNProcessNApproachN(9thNEdition,N2017)
PHARMACOLOGYN9THNEDITIONNMCCUISTIONNTESTNBANK
EmergencyNDrugs
, TestNBankN-NPharmacology:NANPatient-
CenteredNNursingNProcessNApproachN(9thNEdition,N2017)
PHARMACOLOGYN9THNEDITIONNMCCUISTIONNTESTNBANK
Chapter 01: Drug Development and Ethical Considerations
N N N N N N
MULTIPLENCHOICE
1. TheNnurseNisNpreparingNtoNadministerNaNscheduleNIINinjectableNdrugNandNisNdrawingNupNhalfN
ofNtheNcontentsNofNaNSingle-useNvial.NWhichNnursingNactionNisNcorrect?
a. AskNanotherNnurseNtoNobserveNandNcosignNwastingNtheNremainingNdrugNfromNtheNvial.
b. KeepNtheNremainingNamountNinNtheNpatient’sNdrawerNtoNgiveNatNtheNnextNdose.
c. RecordNtheNamountNunusedNinNtheNpatient’sNmedicationNrecord.
d. DisposeNofNtheNvialNwithNtheNremainingNdrugNintoNaNlockedNcollectionNbo
x.NANS:NA
ScheduleNIINdrugsNareNcontrolledNsubstances,NandNallNmustNbeNaccountedNfor.NWhenNwasting
NaNportionNofNaNdrug,NanotherNnurseNshouldNobserveNandNcosignNthatNaNdrugNwasNwasted.
DIF:NCOGNITIVENLEVEL:NApplyingN(Application)N
TOP:NNURSINGNPROCESS:NNursingNInterventio
n
MSC:NNCLEX:NPhysiologicalNIntegrity:NPharmacologicalNandNParenteralNTherapies
2. ANpatientNisNprescribedNaNmedicationNandNasksNtheNnurseNifNtheNdrugNisNavailableNinNaNgener
icNform.NTheNnurseNunderstandsNthatNaNgenericNmedicationNwillNhaveNaNnameNthat
a. isNaNregisteredNtrademark.
b. isNalwaysNcapitalized.
c. describesNtheNdrugsNchemicalNstructure.
d. isNnon-
proprietary.NANS:ND
TheNgenericNnameNisNtheNofficial,Nnon-
proprietaryNnameNforNaNdrug.NTheNbrandNnameNisNtheNtrademarkNnameNandNisNalwaysNcapitalized.
NTheNchemicalNnameNdescribesNtheNchemicalNstructureN ofNtheNdrug.
DIF:NCOGNITIVENLEVEL:NUnderstandingN(Comprehension
)NTOP:NNURSINGNPROCESS:NN/A
MSC:NNCLEX:NPhysiologicalNIntegrity:NPharmacologicalNandNParenteralNTherapies
3. ANpatientNreceivesNaNprescriptionNonNwhichNtheNproviderNhasNnotedNthatNaNgenericNmedicati
onNmayNbeNgiven.TheNpatientNasksNtheNnurseNwhatNthisNmeans.NWhatNwillNtheNnurseNtellNtheNpa
tientNaboutNgenericNdrugs?
a. TheyNcontainNtheNsameNinertNingredientsNasNbrand-nameNdrugs.
b. TheyNhaveNchemicalNstructuresNthatNareNidenticalNtoNproprietaryNdrugs.
c. TheyNtendNtoNbeNlessNexpensiveNthanNbrand-nameNdrugs.
d. TheyNundergoNextensiveNtestingNbeforeNtheyNareNmarkete
d.NANS:NC
GenericNdrugsNareNapprovedNbyNtheNFDANifNtheyNareNprovedNtoNbeNbioequivalentNtoNtheNbrand-
NnameNdrug.NTheyNtendNtoNbeNlessNexpensiveNbecauseNmanufacturersNofNtheseNdrugsNdoNnotNhav
eNtoNdoNtheNextensiveNtestingNrequiredNofNbrand-
nameNdrugsNbeforeNmarketing.NTheyNareNnotNidenticalNtoNbrand-
nameNdrugsNandNoftenNhaveNdifferentNinertNingredients.
DIF:NCOGNITIVENLEVEL:NApplyingN(Application)
TOP:NNURSINGNPROCESS:NNursingNIntervention:NPatientNTeachingN
MSC:NNCLEX:NManagementNofNClientNCare
4. TheNnurseNreviewsNinformationNaboutNaNdrugNandNnotesNtheNinitialsNUSPNafterNtheNdrugsNoffici
alNname.NTheNnurseNunderstandsNthatNthisNdesignationNindicatesNtheNdrug
a. isNaNcontrolledNsubstance.
